BF-B
Brown-Forman Corporation
BF-B's fundamentals are mixed, but it looks cheap: trading at 19x earnings, about half its usual 36x. Analysts expect earnings growth.
BF-B Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
BF-B's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
BF-B PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $25.70 | -14% |
| Forward | 18x | $30.04 | — |
| Current | 19x | $30.04 | — |
| Fair | 36x | $55.07 | +83% |
| Expensive | 40x | $62.69 | +109% |
Historical ranges are pointers, not guarantees.
BF-B's PE is in its cheap range at 19x. If earnings grow as analysts expect, today's price would be 18x next year's earnings.
BF-B Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect BF-B's earnings to grow and its profitability to improve, with its revenue holding steady.
BF-B Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.70 | +9.7% |
| Q3 2026 | $1.55 | -13% |
| Q2 2026 | $1.53 | -17% |
| Q1 2026 | $1.72 | -18% |
| Q4 2025 | $1.71 | -19% |
| Q3 2025 | $1.79 | -14% |
| Q2 2025 | $1.84 | -14% |
| Q1 2025 | $2.09 | +4% |
| Q4 2024 | $2.12 | +31% |
BF-B's earnings per share have fallen from their peak: $1.55 over the past year, against $2.14 in early 2024.
BF-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $911M | -1.4% |
| Q2 2026 | $912M | +2% |
| Q1 2026 | $1.1B | +2% |
| Q4 2025 | $1B | -5.4% |
| Q3 2025 | $924M | -2.8% |
| Q2 2025 | $894M | -7.3% |
| Q1 2025 | $1B | -3.2% |
| Q4 2024 | $1.1B | -1.1% |
BF-B's revenue fell from its 2023 peak and has held roughly level since: $911M last quarter, down 1.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | -0.5 points |
| Q2 2026 | 11% | -12 points |
| Q1 2026 | 32% | +5.2 points |
| Q4 2025 | 29% | -1.7 points |
| Q3 2025 | 28% | -1.4 points |
| Q2 2025 | 23% | -16 points |
| Q1 2025 | 27% | -7.8 points |
| Q4 2024 | 31% | +0.5 points |
BF-B's operating margin was 28% last quarter, about level with the same quarter a year ago.
BF-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $161M | +25% |
| Q2 2026 | $265M | +160% |
| Q1 2026 | $392M | +44% |
| Q4 2025 | $107M | +32% |
| Q3 2025 | $129M | +$153M |
| Q2 2025 | $102M | -50% |
| Q1 2025 | $272M | +39% |
| Q4 2024 | $81M | +179% |
BF-B generated $925M in free cash flow over the past year, up 58% from the year before.
BF-B Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -7.2M shares |
| 1 year | -2.8% | -13.4M shares |
| 3 years | -4.3% | -20.9M shares |
| 5 years | -4.4% | -21.2M shares |
| Available history | -4.4% | -21M shares |
BF-B has 460M diluted shares, down 2.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $301M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q2 2024 | — |
| Q1 2024 | $358M |
| Q2 2021 | — |
| Q1 2021 | — |
BF-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.9x | Healthy |
BF-B's net debt is about 2.0 years of its operating earnings (EBITDA), about the same as a year ago.
BF-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.1 | Neutral |
| Stochastic | 74.8 | Neutral |
BF-B's weekly RSI is 60 (neutral) and its Stochastic is 75 (neutral).
BF-B PE vs Consumer Defensive Sector
| Metric | BF-B | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 19x | 0.9% below |
| PE % | 27 | 18 | 9 pts above |
BF-B is trading at 19x earnings, in line with the Consumer Defensive sector's median of 19x.
BF-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.3 | 6.2% above |
| 20 week MA | $27.5 | 9.1% above |
| 50 week MA | $27.4 | 9.6% above |
| 100 week MA | $29.3 | 2.5% above |
| 200 week MA | $42.5 | 29% below |
BF-B has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 29% below its 200-week average.
BF-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $67.9 | $78.0 | +15% |
| 2021 | $78.0 | $71.7 | -8.1% |
| 2022 | $71.7 | $66.4 | -7.5% |
| 2023 | $66.4 | $57.1 | -14% |
| 2024 | $57.1 | $38.8 | -32% |
| 2025 | $38.8 | $26.2 | -33% |
| 2026 YTD | $26.2 | $30.0 | +15% |
BF-B has finished five years in a row lower, and it's up 15% so far in 2026.